Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Bio Rad Labs Inc (BIO)

390 + Investors. Track Smart Money conviction in BIO. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +3
Streak
4Q ▲
Buyers last Q
45%

Smart Money Signals — BIO

Based on 396 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 4 quarters in a row

last 6Q
For 4 consecutive quarters, more hedge funds added BIO than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
📊

High ownership — 85% of 3.0Y peak

85% of all-time peak
396 funds currently hold this stock — 85% of the 3.0-year high of 467 funds (reached 2023 Q4). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
📶

Steady growth — +4% more funds vs a year ago

fund count last 6Q
+16 new funds entered over the past year (+4% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟠

More sellers than buyers — 45% buying

178 buying215 selling
Last quarter: 215 funds reduced or exited vs 178 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.
➡️

Steady new buyers — ~64 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 64 → 64 → 64 → 64. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

68% of holders stayed for 2+ years

■ 68% conviction (2yr+) ■ 17% medium ■ 15% new
268 out of 396 hedge funds have held BIO for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares +27%, value +3%

Value
+3%
Shares
+27%
Last quarter: funds added +27% more shares while total portfolio value only changed +3%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
➡️

Steady discovery — ~64 new funds/quarter

59 → 64 → 64 → 64 → 64 new funds/Q
New funds entering each quarter: 64 → 64 → 64 → 64. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🏛️

Veteran-anchored — 71% veterans vs 19% newcomers

■ 71% veterans ■ 10% 1-2yr ■ 19% new
Entry-cohort mix of 399 holders: 283 (71%) are 2+ year veterans, 40 entered 1–2 years ago, and 76 (19%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 48% AUM from top-100 funds

48% from top-100 AUM funds
61 of 395 holders are among the 100 largest funds by AUM, controlling 48% of total institutional value in BIO. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
2.9
out of 10
Low Exit Risk
Exit risk score 2.9/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — BIO

In 2026 Q2, 178 hedge funds were net buyers of BIO (64 opened a new position, 114 added to an existing one), while 215 reduced or exited (154 trimmed, 61 sold completely) — a 45% buyer ratio, indicating roughly balanced activity. This marks 4 consecutive quarters of net institutional buying — a persistent conviction signal. 48% of total institutional value in BIO is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +3 funds (more new holders than closures). Total institutional holders: 396.

Hedge Fund Ownership: BIO

How many hedge funds hold BIO — quarterly history vs. share price
Quarterly hedge fund ownership of BIO vs. share price

Market Analysis: BIO

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: BIO

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Loading signal freshness…
Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

15 top-rated funds 5 high-conviction
Consensus
5.2
/ 10
breadth
×
Elite
2.7
/ 10
conviction
Hedge Fund Positioning: BIO
390 + Investors

Track Smart Money conviction in BIO. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 390 393 -0.76%
13F Shares 19M 20M -3.18%
Total Value $5.48B $5.34B 2.57%
New Positions 62 64 -2
Increased Positions 111 141 -30
Closed Positions 64 62 +2
Reduced Positions 153 101 +52
Total Calls 3 4 -25.0%
Total Puts 1 1 -
PUT/CALL Ratio 0.33 0.25 Bullish

Statistics: BIO

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

390 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in BIO. Verified SEC 13F-HR filings.

QUARTER:
Top 25 BIO holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 QVIDTVM Management LLC 25.39% 66,243 $19.4M
2 JNE Partners LLP 10.68% 88,511 $26.0M
3 Tikvah Management LLC 6.12% 68,604 $20.1M
4 Palliser Capital (UK) Ltd 4.41% 27,954 $8.2M
5 Mangrove Partners IM, LLC 2.45% 127,191 $37.3M
6 Ariel Investments, LLC 2.39% 816,751 $239.8M
7 Sector Gamma As 2.12% 33,350 $9.8M
8 First Pacific Advisors, LP 1.46% 401,861 $118.0M
9 AYAL Capital Advisors Ltd 1.30% 16,333 $4.8M
10 Pavaki Capital Management LLC 1.28% 6,000 $1.8M
11 First Eagle Investment Management, LLC 1.28% 2,606,219 $765.2M
12 Arnhold LLC 1.14% 55,568 $16.3M
13 Nano Cap New Millennium Growth Fund L P 1.13% 5,000 $1.5M
14 Hosking Partners LLP 0.92% 94,430 $27.7M
15 Hound Partners, LLC 0.76% 22,481 $6.6M
16 Deerfield Management Company, L.P. 0.69% 226,070 $66.4M
17 Earnest Partners LLC 0.61% 580,752 $170.5M
18 Slotnik Capital, LLC 0.57% 7,500 $2.2M
19 Marathon Asset Management Ltd 0.50% 41,975 $12.3M
20 Portolan Capital Management, LLC 0.47% 42,620 $12.5M
21 Hara Capital LLC 0.46% 2,981 $875K
22 Concentric Capital Strategies, LP 0.39% 23,692 $7.0M
23 Westport Asset Management Inc 0.36% 3,000 $881K
24 PFM Health Sciences, LP 0.35% 13,995 $4.1M
25 Focused Alpha, LLC 0.32% 4,205 $1.2M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Bio Rad Labs Inc (BIO)

What does the Smart Money Trend signal show for BIO?

Buying streak — 4 quarters in a row: For 4 consecutive quarters, more hedge funds added BIO than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for BIO?

More sellers than buyers — 45% buying: Last quarter: 215 funds reduced or exited vs 178 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for BIO holders?

Elite ownership — 48% AUM from top-100 funds: 61 of 395 holders are among the 100 largest funds by AUM, controlling 48% of total institutional value in BIO. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held BIO?

68% of holders stayed for 2+ years: 268 out of 396 hedge funds have held BIO for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →